Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance.
Francis
Geoffrey
G
Duggan
Anne
A
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D000069285:Infliximab; D016896:Treatment Outcome; D028761:Withholding Treatment
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab